logo
  Home | Contact us | Browse | Quick Search by UniProtKB ID, Keyword, PDBID

Menu:

Latest news:

Sep. 10, 2014:
A total of 174 experimentally verified S-nitrosylation sites on 94 S-nitrosylated proteins from individualized human colorectal cancer tissues using a label-free quantitation strategy.

Read more...


Protein Name: Nitric oxide synthase, endothelial

UniprotKB/SwissProt ID: NOS3_HUMAN (P29474)

Gene Name: NOS3

Organism: Homo sapiens (Human).

Function: Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets. Isoform eNOS13C: Lacks eNOS activity, dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Cell membrane. Membrane, caveola. Cytoplasm, cytoskeleton. Golgi apparatus. Note=Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced enzymatic activity.

PDB :
( If your security settings prevent Jmol from running, please register http://140.138.144.145/ as a safe location in your Java settings. )

Protein disease:
Disease database Database Entry Disease information
OMIM104300ALZHEIMER DISEASE; AD ;;PRESENILE AND SENILE DEMENTIA ALZHEIMER DISEASE, FAMILIAL, 1, INCLUD
OMIM145500HYPERTENSION, ESSENTIAL ;;EHT
OMIM163729NITRIC OXIDE SYNTHASE 3; NOS3 ;;NITRIC OXIDE SYNTHASE, ENDOTHELIAL; ENOS CORONARY ARTERY SPA
OMIM601367STROKE, ISCHEMIC ;;CEREBROVASCULAR ACCIDENT;; CEREBRAL INFARCTION
HPRD01224Coronary spasms, susceptibility to
Network with metabolic pathway:
Kegg map ID Pathway Link
map00330Arginine and proline metabolism
map04066HIF-1 signaling pathway
map04370VEGF signaling pathway
map04020Calcium signaling pathway
map04151PI3K-Akt signaling pathway
Graphical Visualization of S-nitrosylation Sites:
Overview of Protein S-nitrosylation Sites with Functional and Structural Information
InterPro ID Domain
IPR001433
IPR003097
IPR004030
IPR008254
IPR012144

3D Structure Databases:
3D structure databases
EntryMethodResolution (A)ChainPositionsView
1M9J X-ray 2.43 A A/B67-481Link
1M9K X-ray 2.01 A A/B67-481Link
1M9M X-ray 1.96 A A/B67-481Link
1M9Q X-ray 2.01 A A/B67-481Link
1M9R X-ray 2.56 A A/B67-481Link
1NIW X-ray 2.05 A B/D/F/H492-511Link
2LL7 NMR - B493-509Link
3EAH X-ray 2.44 A A/B66-492Link
3NOS X-ray 2.40 A A/B66-492Link

The S-nitrosylation sites of NOS3_HUMAN

No. Position S-nitrosylated Peptide Secondary Structure of S-nitrosylated Peptide Solvent Accessibility of nitrosylated Site Substrate Motifs PubMed ID Experiment
194LSAQAQQDGP C TPRRCLGSLV EEECCCCCCC C CHHHHHHEEE 11.35%HC0622178444-
294LSAQAQQDGP C TPRRCLGSLV EEECCCCCCC C CHHHHHHEEE 11.35%HC0615774480-
394LSAQAQQDGP C TPRRCLGSLV EEECCCCCCC C CHHHHHHEEE 11.35%HC0617941803-
499QQDGPCTPRR C LGSLVFPRKL CCCCCCCHHH H HHEEECCCCC 5.50%HC0922178444-
599QQDGPCTPRR C LGSLVFPRKL CCCCCCCHHH H HHEEECCCCC 5.50%HC0916081307-
699QQDGPCTPRR C LGSLVFPRKL CCCCCCCHHH H HHEEECCCCC 5.50%HC0917941803-
7184AKQAWRNAPR C VGRIQWGKLQ HHHHHCCCCC E EEEEEECCCC 3.56%HC0222178444-
8184AKQAWRNAPR C VGRIQWGKLQ HHHHHCCCCC E EEEEEECCCC 3.56%HC0216081307-
9201GKLQVFDARD C RSAQEMFTYI CCCCEEEECC C CCHHHHHHHH 2.85%HC0322178444-
10201GKLQVFDARD C RSAQEMFTYI CCCCEEEECC C CCHHHHHHHH 2.85%HC0316081307-
11212RSAQEMFTYI C NHIKYATNRG CCHHHHHHHH H HHHHHHHCCC 1.82%HC0522178444-
12212RSAQEMFTYI C NHIKYATNRG CCHHHHHHHH H HHHHHHHCCC 1.82%HC0516081307-
13661GLGSRAYPHF C AFARAVDTRL EECCCCHHHH H HHHHHHHHHH 2.50%HC0922178444-
14661GLGSRAYPHF C AFARAVDTRL EECCCCHHHH H HHHHHHHHHH 2.50%HC0917941803-
15802QYQPGDHIGV C PPNRPGLVEA CCCCCCEEEE C CCCCHHHHHH 3.80%HC1222178444-
16802QYQPGDHIGV C PPNRPGLVEA CCCCCCEEEE C CCCCHHHHHH 3.80%HC1217941803-
17853GWVRDPRLPP C TLRQALTFFL CCCCCCCCCC C CHHHHHHHHE 5.45%HC0122178444-
18853GWVRDPRLPP C TLRQALTFFL CCCCCCCCCC C CHHHHHHHHE 5.45%HC0117941803-
19976DGLGPLHYGV C STWLSQLKPG CCCCCCCCCC C HHHHHHCCCC 2.32%HC1222178444-
20976DGLGPLHYGV C STWLSQLKPG CCCCCCCCCC C HHHHHHCCCC 2.32%HC1217941803-
21991SQLKPGDPVP C FIRGAPSFRL HHCCCCCEEE E EEECCCCCCC 4.51%HC0122178444-
22991SQLKPGDPVP C FIRGAPSFRL HHCCCCCEEE E EEECCCCCCC 4.51%HC0117941803-
231048QPTPMTLVFG C RCSQLDHLYR CCCEEEEEEE C CCCCHHHHHH 2.42%HC1022178444-
241048QPTPMTLVFG C RCSQLDHLYR CCCEEEEEEE C CCCCHHHHHH 2.42%HC1017941803-
251050TPMTLVFGCR C SQLDHLYRDE CEEEEEEECC C CCHHHHHHHH 3.37%HC0222178444-
261050TPMTLVFGCR C SQLDHLYRDE CEEEEEEECC C CCHHHHHHHH 3.37%HC0217941803-
271114LCLERGHMFV C GDVTMATNVL HCCCCCEEEE E CCCCHHHHHH 2.35%HC1222178444-
281114LCLERGHMFV C GDVTMATNVL HCCCCCEEEE E CCCCHHHHHH 2.35%HC1217941803-